DHI Group, Inc. provides data, insights, and employment connections through specialized services for technology professionals and other select online communities in the United States. Its ...
After hours: March 13 at 6:16:25 p.m. EDT Loading Chart for DHX ...
Stay updated on market trends for SLN. Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% Lp(a) reduction in ASCVD patients but faces dosing frequency challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback